You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 1, January 4, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transmission of Human Granulocytic Ehrlichiosis

Kurt D. Reed, MD; Paul D. Mitchell, PhD
Marshfield Laboratories Marshfield, Wis

David H. Persing, MD, PhD; Chris P. Kolbert, MS
Mayo Clinic Rochester, Minn

Vinoo Cameron, MD
Athens, Wis

JAMA. 1995;273(1):23.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The recent discovery of human granulocytic ehrlichiosis (HGE) in Wisconsin and Minnesota1,2 is highly significant because it alerts physicians to the presence of a potentially fatal but generally treatable disease. Our recent experiences support the described clinical presentations of the disease, and the following case report provides preliminary evidence that Ixodes scapularis is a vector of HGE.

In the fall of 1993, a 57-year-old man who resided in central Wisconsin presented to his personal physician with a temperature of 40°C, severe chills, and myalgias. The patient had recently returned from a visit to northwestern Wisconsin. On physical examination of the patient, the physician found an engorged tick, identified as an adult female I scapularis, slightly embedded in the patient's back. Treatment was initiated with doxycycline, and dramatic improvement in the patient's condition was noted within 48 hours. To date, there has not been a recurrence of . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.